281 related articles for article (PubMed ID: 30031170)
1. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53.
Zhao Y; Zhang L; Wu Y; Dai Q; Zhou Y; Li Z; Yang L; Guo Q; Lu N
Pharmacol Res; 2018 Sep; 135():49-59. PubMed ID: 30031170
[TBL] [Abstract][Full Text] [Related]
2. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.
Zhao K; Zhou Y; Qiao C; Ni T; Li Z; Wang X; Guo Q; Lu N; Wei L
J Hematol Oncol; 2015 Apr; 8():41. PubMed ID: 25902914
[TBL] [Abstract][Full Text] [Related]
3. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
4. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
Huang KF; Zhang GD; Huang YQ; Diao Y
Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
[TBL] [Abstract][Full Text] [Related]
5. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.
Dai Q; Yin Y; Liu W; Wei L; Zhou Y; Li Z; You Q; Lu N; Guo Q
Int J Biochem Cell Biol; 2013 Jul; 45(7):1468-78. PubMed ID: 23612020
[TBL] [Abstract][Full Text] [Related]
6. Wogonin inhibits the growth of HT144 melanoma via regulating hedgehog signaling-mediated inflammation and glycolysis.
Li L; Ji Y; Zhang L; Cai H; Ji Z; Gu L; Yang S
Int Immunopharmacol; 2021 Dec; 101(Pt B):108222. PubMed ID: 34688155
[TBL] [Abstract][Full Text] [Related]
7. Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells.
Yao Z; Xie F; Li M; Liang Z; Xu W; Yang J; Liu C; Li H; Zhou H; Qu LH
Cell Death Dis; 2017 Feb; 8(2):e2633. PubMed ID: 28230866
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
Rajeshkumar NV; Dutta P; Yabuuchi S; de Wilde RF; Martinez GV; Le A; Kamphorst JJ; Rabinowitz JD; Jain SK; Hidalgo M; Dang CV; Gillies RJ; Maitra A
Cancer Res; 2015 Aug; 75(16):3355-64. PubMed ID: 26113084
[TBL] [Abstract][Full Text] [Related]
9. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathways.
Huynh DL; Sharma N; Kumar Singh A; Singh Sodhi S; Zhang JJ; Mongre RK; Ghosh M; Kim N; Ho Park Y; Kee Jeong D
Chin J Nat Med; 2017 Jan; 15(1):15-40. PubMed ID: 28259249
[TBL] [Abstract][Full Text] [Related]
11. Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3.
Wang Y; Wu S; Huang C; Li Y; Zhao H; Kasim V
Cancer Sci; 2018 Aug; 109(8):2423-2434. PubMed ID: 29869834
[TBL] [Abstract][Full Text] [Related]
12. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
Gomes AS; Ramos H; Soares J; Saraiva L
Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
[TBL] [Abstract][Full Text] [Related]
13. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.
Zawacka-Pankau J; Grinkevich VV; Hünten S; Nikulenkov F; Gluch A; Li H; Enge M; Kel A; Selivanova G
J Biol Chem; 2011 Dec; 286(48):41600-41615. PubMed ID: 21862591
[TBL] [Abstract][Full Text] [Related]
16. Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity.
Wang J; Li T; Zhao T; Wu T; Liu C; Ding H; Li Z; Bian J
Eur J Med Chem; 2019 Sep; 178():782-801. PubMed ID: 31238183
[TBL] [Abstract][Full Text] [Related]
17. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins.
Yang L; Wang Q; Li D; Zhou Y; Zheng X; Sun H; Yan J; Zhang L; Lin Y; Wang X
Apoptosis; 2013 May; 18(5):618-26. PubMed ID: 23371323
[TBL] [Abstract][Full Text] [Related]
18. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin.
Dong P; Zhang Y; Gu J; Wu W; Li M; Yang J; Zhang L; Lu J; Mu J; Chen L; Li S; Wang J; Liu Y
J Ethnopharmacol; 2011 Oct; 137(3):1373-80. PubMed ID: 21855619
[TBL] [Abstract][Full Text] [Related]
19. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway.
Huang Q; Li J; Xing J; Li W; Li H; Ke X; Zhang J; Ren T; Shang Y; Yang H; Jiang J; Chen Z
J Hepatol; 2014 Oct; 61(4):859-66. PubMed ID: 24801417
[TBL] [Abstract][Full Text] [Related]
20. Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity.
Brandão P; Loureiro JB; Carvalho S; Hamadou MH; Cravo S; Moreira J; Pereira D; Palmeira A; Pinto M; Saraiva L; Cidade H
Eur J Med Chem; 2018 Aug; 156():711-721. PubMed ID: 30041135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
